AI ScreeningAI ChatPricing
  1. US-listed companies
  2. ALNYLAM PHARMACEUTICALS, INC.
  3. Financials
  4. Return on Assets

ALNYLAM PHARMACEUTICALS, INC.【ALNY】

Market cap
$41.5B
P/E ratio
SummaryFinancials
Period EndReturn on Assets (Million USD)YoY (%)
Dec 31, 2024-6.9-42.29%
Dec 31, 2023-11.9-62.06%
Dec 31, 2022-31.5+30.10%
Dec 31, 2021-24.2-18.22%
Dec 31, 2020-29.6-33.74%
Dec 31, 2019-44.6+4.62%
Dec 31, 2018-42.7+41.57%
Dec 31, 2017-30.1-2.65%
Dec 31, 2016-31+31.63%
Dec 31, 2015-23.5-51.05%
Dec 31, 2014-48+90.67%
Dec 31, 2013-25.2-32.31%
Dec 31, 2012-37.2+117.97%
Dec 31, 2011-17.1

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)